H Niitani
- Co-authors
- Kazuo HasegawaM. FukuokaT TaguchiShunichi NegoroH FurueYuichi KuritaKiyoyuki FuruseA Wakui
- Topics
- Cancer Treatment and Pharmacology (22 papers)Lung Cancer Treatments and Mutations (19 papers)Nausea and vomiting management (13 papers)
In The Last Decade
H Niitani
49 papers receiving 398 citations
Peers
Comparison fields: 5 of 58
- Oncology 316
- Molecular Biology 188
- Pulmonary and Respiratory Medicine 183
- Surgery 63
- Epidemiology 54
Countries citing papers authored by H Niitani
This map shows the geographic impact of H Niitani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Niitani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Niitani more than expected).
Fields of papers citing papers by H Niitani
This network shows the impact of papers produced by H Niitani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Niitani. The network helps show where H Niitani may publish in the future.
Co-authorship network of co-authors of H Niitani
This figure shows the co-authorship network connecting the top 25 collaborators of H Niitani. A scholar is included among the top collaborators of H Niitani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H Niitani. H Niitani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | [The development of a new QOL Questionnaire on chemotherapy - induced emesis and vomiting--investigation of reliability and validity. Group for Investigation of QOL Questionnaire for Anti-Emetics Used in Cancer Chemotherapy. Joint Research Group for Tropisetron Double-Blind Comparative study]. | 2 |
| 3 | [Effects of an anti-emetic tropisetron capsule on QOL of patients with delayed nausea and vomiting induced by cancer chemotherapy. Group for Investigation of QOL Questionnaire for Anti-Emetics used in Cancer Chemotherapy. Joint Research Group for Tropisetron Double-Blind Comparative Study]. | 1 |
| 4 | 4 | |
| 5 | [Clinical phase II study of tropisetron capsule in the treatment of nausea and vomiting induced by anti-cancer drugs]. | 1 |
| 6 | [Clinical phase III study of tropisetron capsule in the treatment of nausea and vomiting induced by anti-cancer drug; a placebo-controlled, multicenter, double-blind comparative study]. | 1 |
| 7 | 21 | |
| 8 | 3 | |
| 9 | [Clinical evaluation of granisetron for nausea and vomiting induced by anticancer drugs--optimal dose-finding study]. | 8 |
| 10 | [Anti-emetic effect and safety of consecutive use of ondansetron injection in cisplatin-induced nausea and emesis]. | 0 |
| 11 | [Examination of inhibitory effect, safety and usefulness of SN-307 (ondansetron) administered orally once daily for 3-5 consecutive days on nausea and emesis associated with non-platinum anti-cancer drugs]. | 1 |
| 12 | [Anti-emetic effect and safety of single dose of ondansetron injection in double-blind comparison study with placebo]. | 3 |
| 13 | [Anti-emetic effect and safety of ondansetron tablet in double-blind comparison with placebo]. | 3 |
| 14 | 9 | |
| 15 | [Phase I clinical study of CPT-11. Research group of CPT-11]. | 58 |
| 16 | [New treatments for urogenital toxicity of anti-neoplastic chemotherapy]. | 1 |
| 17 | 3 | |
| 18 | [Guidelines for the clinical evaluation of antineoplastic drugs]. | 4 |
| 19 | 3 | |
| 20 | [A phase II study of NK171 (etoposide)]. | 2 |
About H Niitani
H Niitani is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Complementary and alternative medicine, having authored 53 papers that have together received 431 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (22 papers), Lung Cancer Treatments and Mutations (19 papers) and Nausea and vomiting management (13 papers). The work is most often cited by research in Oncology (316 citations), Pulmonary and Respiratory Medicine (183 citations) and Molecular Biology (188 citations). H Niitani has collaborated with scholars based in Japan, Greece and Pakistan. Frequent co-authors include Kazuo Hasegawa, M. Fukuoka, T Taguchi, Shunichi Negoro, H Furue, Yuichi Kurita, Kiyoyuki Furuse, A Wakui, Toshihiro Nakabayashi and Masakichi Motomiya. Their work appears in journals such as Circulation, Journal of Molecular and Cellular Cardiology and Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.